114 related articles for article (PubMed ID: 7431108)
1. Binding of technetium-99m to plasma proteins: influence on the distribution of Tc-99m phosphate agents.
Schümichen C; Koch K; Kraus A; Kuhlicke G; Weiler K; Wenn A; Hoffman G
J Nucl Med; 1980 Nov; 21(11):1080-5. PubMed ID: 7431108
[TBL] [Abstract][Full Text] [Related]
2. Is (99m)Tc-labelled pamidronate a better agent than (99m)Tc-medronate for bone imaging?
Kumar V; Kumar D; Howman-Giles RB; Little DG
Nucl Med Commun; 2007 Feb; 28(2):101-7. PubMed ID: 17198350
[TBL] [Abstract][Full Text] [Related]
3. Uptake of Tc-99m monophosphate complexes in bone and myocardial necrosis in animals.
Kung HF; Ackerhalt R; Blau M
J Nucl Med; 1978 Sep; 19(9):1027-31. PubMed ID: 690703
[TBL] [Abstract][Full Text] [Related]
4. Tc-99m methylene diphosphonate versus Tc-99m pyrophosphate: biologic and clinical comparison.
Rudd TG; Allen DR; Hartnett DE
J Nucl Med; 1977 Sep; 18(9):872-6. PubMed ID: 197133
[TBL] [Abstract][Full Text] [Related]
5. Tc-99m DMSA renal uptake: influence of biochemical and physiologic factors.
Yee CA; Lee HB; Blaufox MD
J Nucl Med; 1981 Dec; 22(12):1054-8. PubMed ID: 6273511
[TBL] [Abstract][Full Text] [Related]
6. Kinetics of 99mTc-labeled pyrophosphate and polyphosphate in man.
Krishnamurthy GT; Huebotter RJ; Walsh CF; Taylor JR; Kehr MD; Tubis M; Blahd WH
J Nucl Med; 1975 Feb; 16(2):109-15. PubMed ID: 162949
[TBL] [Abstract][Full Text] [Related]
7. Validation of ultrafiltration as a method of measuring free 99mTc-MDP.
Moore AE; Hain SF; Blake GM; Fogelman I
J Nucl Med; 2003 Jun; 44(6):891-7. PubMed ID: 12791815
[TBL] [Abstract][Full Text] [Related]
8. Biological distribution and excretion of DTPA labeled with Tc-99m and In-111.
McAfee JG; Gagne G; Atkins HL; Kirchner PT; Reba RC; Blaufox MD; Smith EM
J Nucl Med; 1979 Dec; 20(12):1273-8. PubMed ID: 536795
[TBL] [Abstract][Full Text] [Related]
9. Bone uptake of 99mTc-phosphate via labeled plasma protein.
Schümichen C; Seifritz R; Hoffmann G
Nuklearmedizin; 1980 Aug; 19(4):174-7. PubMed ID: 6259628
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the biodistribution and tumor targeting of two 99mTc-labeled anti-EGFR nanobodies in mice, using pinhole SPECT/micro-CT.
Gainkam LO; Huang L; Caveliers V; Keyaerts M; Hernot S; Vaneycken I; Vanhove C; Revets H; De Baetselier P; Lahoutte T
J Nucl Med; 2008 May; 49(5):788-95. PubMed ID: 18413403
[TBL] [Abstract][Full Text] [Related]
11. Preparation and biological distribution of technetium diphosphonate radiotracers synthesized without stannous ion.
Deutsch E; Libson K; Becker CB; Francis MD; Tofe AJ; Ferguson DL; McCreary LD
J Nucl Med; 1980 Sep; 21(9):859-66. PubMed ID: 6774066
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, characterization, and biological evaluation of neutral nitrido technetium(V) mixed ligand complexes containing dithiolates and aminodiphosphines. A novel system for linking technetium to biomolecules.
Bolzati C; Benini E; Cazzola E; Jung C; Tisato F; Refosco F; Pietzsch HJ; Spies H; Uccelli L; Duatti A
Bioconjug Chem; 2004; 15(3):628-37. PubMed ID: 15149191
[TBL] [Abstract][Full Text] [Related]
13. Detection of sites of infection in mice using 99mTc-labeled PN(2)S-PEG conjugated to UBI and 99mTc-UBI: a comparative biodistribution study.
Meléndez-Alafort L; Nadali A; Pasut G; Zangoni E; De Caro R; Cariolato L; Giron MC; Castagliuolo I; Veronese FM; Mazzi U
Nucl Med Biol; 2009 Jan; 36(1):57-64. PubMed ID: 19181269
[TBL] [Abstract][Full Text] [Related]
14. [Clinical and experimental evaluation of osteotropic radiopharmaceutical preparations].
Korsunskiĭ VN; Tarasov NF; Koval'chuk ND; Levin VI; Boldyrev PP
Med Radiol (Mosk); 1980 Sep; 25(9):9-13. PubMed ID: 6252408
[No Abstract] [Full Text] [Related]
15. Absorption, uptake and tissue affinity of high-molecular-weight hyaluronan after oral administration in rats and dogs.
Balogh L; Polyak A; Mathe D; Kiraly R; Thuroczy J; Terez M; Janoki G; Ting Y; Bucci LR; Schauss AG
J Agric Food Chem; 2008 Nov; 56(22):10582-93. PubMed ID: 18959406
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and characterization of technetium-99m-labeled tropanes as dopamine transporter-imaging agents.
Meegalla SK; Plössl K; Kung MP; Chumpradit S; Stevenson DA; Kushner SA; McElgin WT; Mozley PD; Kung HF
J Med Chem; 1997 Jan; 40(1):9-17. PubMed ID: 9016323
[TBL] [Abstract][Full Text] [Related]
17. [Comparative evaluation of the accumulation of 99mTc-labeled phosphate compounds in the bones].
Atamaniuk NP; Mechev DS
Eksp Onkol; 1985; 7(1):66-7. PubMed ID: 2983974
[TBL] [Abstract][Full Text] [Related]
18. Comparative evaluation of three diphosphonates: in vitro adsorption (C- 14 labeled) and in vivo osteogenic uptake (Tc-99m complexed).
Francis MD; Ferguson DL; Tofe AJ; Bevan JA; Michaels SE
J Nucl Med; 1980 Dec; 21(12):1185-9. PubMed ID: 6449567
[TBL] [Abstract][Full Text] [Related]
19. Pharmacologic alterations in Tc-99m binding by red blood cells: concise communication.
Lee HB; Wexler JP; Scharf SC; Blaufox MD
J Nucl Med; 1983 May; 24(5):397-401. PubMed ID: 6341514
[TBL] [Abstract][Full Text] [Related]
20. Pharmaco-kinetics of current skeletal-seeking radiopharmaceuticals.
Krishnamurthy GT; Huebotter RJ; Tubis M; Blahd WH
AJR Am J Roentgenol; 1976 Feb; 126(2):293-301. PubMed ID: 175699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
